Study of auditory function in patients with chronic obstructive pulmonary diseases

被引:23
|
作者
El-Kady, MA
Durrant, JD
Tawfik, S
Abdel-Ghany, S
Moussa, AM
机构
[1] Univ Pittsburgh, Dept Commun Sci & Disorders & Otolaryngol, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15260 USA
[3] Ain Shams Univ, Dept Audiol, Cairo, Egypt
[4] Sohag Univ Hosp, Dept Chest Dis, Sohag, Egypt
[5] Sohag Univ Hosp, Dept Otolaryngol, Sohag, Egypt
关键词
hypoxia; hypoxemia; chronic obstructive pulmonary disease; electrocochleography; auditory brain-stem response; otoacoustic emissions; audiometry;
D O I
10.1016/j.heares.2005.05.018
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
This study was designed to measure auditory function in patients with chronic obstructive pulmonary diseases (COPDs) who generally suffer from chronic hypoxemia. Control and COPD subject groups received a battery of tests to assess overall hearing sensitivity and peripheral (end-organ and eighth-nerve) and brain-stem auditory function, as well as blood-gas analysis. Results showed a statistically significant difference for all audiological measures between the control group and a COPD subgroup - the presumptive hypoxic subjects (partial oxygen tensions, PO2, < 75 mm Hg). Correlation analyses of results from all subjects (regardless Of PO2) also revealed significant covariance with PO2 for overall, RMS, amplitude of click-evoked otoacoustic emissions (RA), hearing threshold level, and auditory brain-stem response (ABR, I-V inter-peak latency). chi(2) or Fisher's exact tests were statistically significant for frequencies of cases classified according to a criterion PO2 of 70 mm Hg (putative critical O-2 for completely normal auditory function) and either hearing thresholds falling below or RA values above 1.5 standard deviations of the control-group means, respectively. However, chi(2) was not significant for a comparable criterion of ABR IN IPL. In general, clinically significant hearing loss was uncommon in COPD patients, and the observed effects represented relatively small changes in the auditory measures examined. Still, overall, changes were in the direction of poorer function, and these results suggest physiologically significant impact of chronic hypoxemia and the need for further study to evaluate thoroughly this medical condition as a potential risk factor for audio-vestibular dysfunction. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [31] Cardiac structure and function in patients with chronic obstructive pulmonary disease
    Vesterlev, D.
    Reimer Jensen, A. M.
    Duus, L. S.
    Janner, E. H.
    Karsum, E.
    Christensen, J.
    Yafasov, M. K.
    Johansen, N. D.
    Sivapalan, P.
    Ulrik, C. S.
    Lapperre, T.
    Browatzki, A.
    Jensen, J. U. S.
    Biering-Soerensen, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [32] The relationship between cholesterol metabolism and mitochondrial function in chronic obstructive pulmonary diseases
    Li, Liyang
    Wang, Xiangdong
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2022, 2 (03):
  • [33] Chronic obstructive pulmonary diseases in patients with ischemic heart disease: 15-year study
    Kozlova, LI
    Buzunov, RV
    Chuchalin, AG
    TERAPEVTICHESKII ARKHIV, 2001, 73 (03) : 27 - 32
  • [34] Effectiveness of an outpatient pulmonary rehabilitation program in patients with chronic obstructive lung diseases: A pilot study
    Rikas, Mohamed
    Jayasinghe, Chamoda
    Dasanayaka, Renuka
    Wadugodapitiya, Surangika
    Yasaratne, Duminda
    RESPIROLOGY, 2023, 28 : 163 - 164
  • [35] THE EFFECTS OF CHRONIC HYPOXEMIA ON CENTRAL AUDITORY PROCESSING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    CUNNINGHAM, DR
    CUNNINGHAM, CA
    VISE, LK
    EAR AND HEARING, 1985, 6 (06): : 297 - 303
  • [36] Chronic obstructive pulmonary diseases, atherosclerosis and chronic inflammation
    Rykhlitska, K.
    Tkach, E.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 204 - 205
  • [37] LACK OF CORRELATION BETWEEN CLINICAL BACKGROUND AND PULMONARY-FUNCTION TESTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASES - RETROSPECTIVE STUDY OF 140 CASES
    KASS, I
    OBRIEN, LE
    ZAMEL, N
    DYKSTERHUIS, JE
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1973, 107 (01): : 64 - 69
  • [38] ANTIHYPERTENSIVE THERAPY WITH GUANABENZ IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASES
    DEITCH, MW
    LITTMAN, GS
    PASCUCCI, VL
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 : S818 - S822
  • [39] Pneumocystis jirovecii genotypes in european patients with chronic obstructive pulmonary diseases
    Totet, Anne
    Gresillon, Karine
    Matos, Olga
    Lundgren, Bettina
    Larsen, Hans Henrik
    Roux, Patricia
    Hauser, Philippe
    Raccurt, Christian
    Nevez, Gilles
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 2006, 53 : S102 - S103
  • [40] Auditory Function of Patients with Obstructive Sleep Apnea Syndrome: A Study
    Gozeler, Mustafa Sitki
    Sengoz, Furkan
    EURASIAN JOURNAL OF MEDICINE, 2020, 52 (02): : 176 - 179